Clinical

Dataset Information

0

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment


ABSTRACT: RATIONALE: Caspofungin acetate or amphotericin B liposomal may be effective in preventing or controlling fever and neutropenia caused by chemotherapy, bone marrow transplantation, or peripheral stem cell transplantation. It is not yet known whether caspofungin acetate or amphotericin B liposomal is more effective for treating these side effects. PURPOSE: Randomized phase III trial to compare the effectiveness of caspofungin acetate with that of amphotericin B liposomal in treating patients who have persistent fever and neutropenia after receiving anticancer therapy.

DISEASE(S): Extramedullary Plasmacytoma,Primary Myelofibrosis,Angioimmunoblastic T-cell Lymphoma,Monoclonal Gammopathy Of Undetermined Significance,Neutropenia,Cancer

PROVIDER: 2005680 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2003401 | ecrin-mdr-crc
2021-03-01 | E-MTAB-8870 | biostudies-arrayexpress
| PRJNA1033353 | ENA
| PRJNA771428 | ENA
2010-12-13 | E-MEXP-2840 | biostudies-arrayexpress
| PRJNA476147 | ENA
2021-03-23 | GSE115825 | GEO
2020-09-01 | GSE146813 | GEO
2018-04-30 | GSE80719 | GEO
| PRJNA169015 | ENA